- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Managing Disparities in Chronic Kidney Disease Through Value-Based Arrangements
On this episode of Managed Care Cast, we speak with Abi Sundaramoorthy, MD, MBA, executive vice president of clinical enterprise at Somatus, on fragmented care in chronic kidney disease, its disproportionate impact on minority communities, and the potential of value-based arrangements to address disparities and promote preventive, effective care.
Affecting 8% of Americans, chronic kidney disease, or CKD, poses a high risk for both adverse cardiovascular outcomes and progression to end-stage kidney disease. Notably, its disproportionate impact on minority communities along with the fragmented nature of care has contributed to a significant cost burden in the US health care system and worsening health outcomes for patients.
On this episode of Managed Care Cast, we speak with Abi Sundaramoorthy, MD, MBA, executive vice president of clinical enterprise at Somatus, a national value-based care company serving patients with underlying kidney disease, on the potential of value-based arrangements to address disparities in CKD and promote preventive, effective care.